Save your seat for this upcoming webinar! Are local IRBs necessary or just a burden on clinical trials, a bottleneck that contributes to delays and cost overruns?
Title: Are Local IRBs Really Necessary?
Many researchers have complained that use of different local IRBs to review each research site for a multicenter trial is extremely inefficient and leads to additional cost burdens and trial delays. Despite this, many US research sites have been hesitant to use a single, central IRB. Is there a substantive difference, in terms of efficiency and effectiveness, between reviews conducted by decentralized (local) and centralized IRBs? What are the pros and cons of each? Are local IRBs really even necessary, or do they just create bottlenecks in modern clinical trials? The webinar will focus on these issues and look at study startup metrics associated with IRBs.
In this webinar we will explore:
- Investigational site relationships with IRBs
- Problems with using local IRBs for multisite studies
- The growing trend of using centralized IRBs and barriers to adoption
- Real-time insights on IRB performance with study startup metrics
This webinar is applicable to:
- Investigative site roles responsible for running trials
- Sponsor and CRO roles responsible for site selection and activation
- Sponsor and CRO roles responsible for collecting and evaluating trial metrics
Tuesday, February 28
1 pm ET
10 am PT
JOAN A. CHAMBERS
Chief Operating Officer
As the Chief Operating Officer for CenterWatch, Joan is responsible for the business operations, financial performance, marketing, and sales of the company along with setting strategic direction.
A well-known speaker at industry conferences and symposiums, Joan has presented on a wide variety of topics specific to the clinical trials enterprise. In the course of her career, she has also published in clinical trade journals. For five years, she was an instructor for Barnett International's CRA/CRC programs on the site identification/qualification process. Joan is on the Advisory Board for BioBridges, Board of Directors for Greater Gift Initiative (GGI), and The Center for Information and Study on Clinical Research Participation (CISCRP), and is an active member of the Association of Clinical Research Professionals (ACRP) and the Drug Information Association (DIA).
Prior to joining CenterWatch in April 2010, Joan spent two and a half years with Cambridge Healthtech Institute as Senior Director of Marketing & Operations-Publications; two and half years with the Tufts Center for the Study of Drug Development at Tufts University as Director of Strategic Marketing & Development; seven and a half years with Thomson CenterWatch as Senior Director of Marketing & Sales; and four years working for PAREXEL International as Site Selection Specialist. Joan holds a B.S. in Marketing.
Christine Pierre is the CEO and Founder of RxTrials, Inc. and the Founder and President of the Society for Clinical Research Sites (SCRS). She is internationally known for her experience and expertise in clinical research site management and patient recruitment and retention for the clinical trials industry. In addition to being a frequent guest speaker at industry conferences, she has also addressed audiences around the world on issues pertaining to human subject protection, site operations, and subject recruitment and retention. Her global reach has included presentations and consulting in Australia, Canada, Africa, Israel, and the United States.
Christine has served as Chairman of the Board of the Association of Clinical Research Professionals (ACRP) and has served on numerous editorial boards of industry publications. She is currently a member of the Steering Committee of the Clinical Trials Transformation Initiative (CTTI), a board member of the Metric Champion Consortium (MCC) and is on the Board of Advisors for both the Center for Information & Study on Clinical Research (CISCRP) and Hands Across the Americas. Learn more
VP Technology & Engineering
Rob has been a computer scientist and programmer for over 30 years in the scientific programming, e-commerce, biotech, and health care industries. He implemented study startup and CTMS functionality at 9 bay are biotech companies, and invented a method that allows medical and biotech organizations to use cloud-based analytics to monitor patient data. He holds a BS in Computer Engineering from Sacramento State University and a PhD in Biological and Biomedical Clinical Informatics from UCSF.